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to polymeric materials such as carbopol is emerging as an 
important mechanism of taste masking.[8] In this study, 
Indion resins were used to mask the taste of bitter drug 
ondansetron. Taste-masking ability of optimized complex, 
molecular properties, and physical characteristics were 
evaluated. The complex of cationic drug and weak cation 
exchange resin does not break at salivary pH (6–7) with 
cation concentration of 40 meq/L. However, at high cation 
concentration of stomach and pH of 1–3, free drug is 
immediately released.
MATERIALS AND METHODS
Materials
Ondansetron (Cipla Ltd., Mumbai, India), Indion 204, Indion 
234, Indion 264 (Ion Exchange Ltd., Mumbai, India), and 
INTRODUCTION
Ion exchange resins are solid and suitably insolublilized 
high-molecular weight polyelectrolytes that can exchange 
their mobile ions of equal charge with the surrounding 
medium reversibly and stochiometrically.[1] The reaction 
is an equilibrium reaction.[2] Various articles describe the 
utility of ion exchange resins for taste masking, sustained 
release, targeted drug delivery, and drug stabilization.[3,4] 
The ion exchange resins are available in different size, 
cross linkage, and functionality making them suitable for 
various applications. Bitter cationic drugs can get adsorbed 
on to weak cationic exchange resin of carboxylic acid 
functionally to form the complex, which is nonbitter.[5] 
The taste-masking applications of ion exchange resins 
are reported for various cationic drugs, e.g., ciprofloxacin, 
chloroquin phosphate.[6,7] The ionic binding of the drugs 
Pharmaceutics
Molecular Properties and Evaluation of Indion 234–Ondansetron 
Resinates
Shah S, Pandya S, Bhalekar MR1
Department of Pharmaceutical Technology, Pioneer Pharmacy Degree College, Vadodara, 1Department of 
Pharmaceutics, AISSMS College of Pharmacy, Pune, India
Address for correspondence: Mr. Samip S. Shah; E-mail: samipshah2008@yahoo.com
ABSTRACT
Ondansetron is a serotonin 5HT3 antagonist; anti-emetic drug. Bitter taste of the ondansetron is a major problem 
in ensuring patient compliance. The study was designed to formulate tasteless complexes of ondansetron with 
ion exchange resin and evaluate molecular properties of drug complex. The drug-loading process was carried out 
using various resins and was optimized using different drug:resin ratio and pH. Resinates were characterized by 
infrared spectroscopy, thermal analysis, and X-ray powder diffraction (XRPD). Indion 234 gave the best loading 
efficiency at drug resin ratio of 1:1.5. pH had no effect on drug loading. XRPD studies revealed that drug is in 
amorphous state in complex. The Infrared studies revealed complexation of secondary amine group of drug 
with carboxylic functional group of resin. Taste evaluation by using semiquantitative method found resonates 
as tasteless and agreeable. The release of drug from resinates in simulated gastric fluid was complete in 30 
min. Thus, ion exchange resinates offer an effective tool for masking of bitterness and improve drug release.
Key words: Indion resin, ondansetron, taste masking
DOI: 10.4103/0975-1483.66799248   J Young Pharm Vol 2 / No 3
β- CD (Lupin Pharmaceutical, Pune, India) were obtained 
as gift samples. All other ingredients used throughout the 
study were of analytical grades and were used as received.
Ion exchange resin[9][Table 1]
Ondansetron[10] [Table 2]
Method of  analysis
The drug was estimated spectrophotometrically at 272.6 
nm using UV–VIS spectrophotometer (V-520, SR type, 
JASCO Corporation, Tokyo, Japan) over concentration 
range of 2–12 µg/mL.
Optimization of drug-loading process
The resin that showed highest loading efficiency was 
optimized for the drug: resin ratio. The loading efficiency 
of optimized ratio was further checked to find optimum 
pH conditions for drug loading.
Drug loading
For drug loading, batch method[11] was used, drug solution 
of concentration 1 mg/mL was prepared in deionized 
water. The required quantity of resin was placed in drug 
solution and was stirred till the attainment of equilibrium. 
Time for attainment of equilibrium was decided to be 
6 h from preliminary experimentation. The slurry was 
filtered, and amount of drug remaining in the filtrate 
was determined spectrophotometrically. The amount of 
drug adsorbed was determined by the difference between 
amount of drug present in stock solution and amount 
remaining in filtrate at the end of equilibrium.
EVALUATION OF RESINATES
Determination of drug content[12]
Resinate (10 mg) was placed in 1 M HCl and stirred at 100 
rpm for 1 h. The solution was filtered (Whatman filter paper 
no. 41) and analyzed for content of ondansetron. Stability 
of complexes was determined by placing weighed quantity 
of complex in deionized water for 24 h and analyzed for 
drug content.
Taste evaluation[13,14]
Evaluation of taste was done in two parts.
Determination of  threshold bitterness concentration 
Various concentrations (1–30 mcg/mL) of drug were 
prepared in phosphate buffer pH 6.7. Mouth was rinsed 
with this solution and then, l0 mL of the most dilute 
solution was tasted by swirling it in the mouth mainly near 
the base of the tongue for 30 s. If the bitter sensation was 
no longer felt in the mouth after 30 s, the solution was spat 
out and wait for 1 min to ascertain whether this is due to 
delayed sensitivity. Then rinse with safe drinking water. The 
next highest concentration should not be tasted until at least 
10 min have passed. The threshold bitter concentration is 
the lowest concentration at which a material continues to 
provoke a bitter sensation after 30 s. After the first series 
of tests, rinse the mouth thoroughly with safe drinking 
water until no bitter sensation remained. Wait for at least 
10 min before carrying out the second test.
In vitro evaluation of  bitter taste of  resinates
An accurately weighed (8 mg drug equivalent) resinate and 
10 mL of pH 6.7 phosphate buffer (0.1 M) was taken in 
series of volumetric flask and stirred at 50 rpm. The stirring 
was stopped at different time intervals such as 0, 10, 30, 60, 
and 120 s, dispersion was filtered, and the concentration 
of ondansetron in filtered resinate was determined. Time 
for resinate to achieve drug concentration corresponding 
to threshold bitterness in 10 mL phosphate buffer is 
recorded.[1] 
Micromeritic properties
Compressibility, angle of repose, and bulk density were 
determined using the methods described in the literature.[15]
X-ray diffraction
X-ray diffraction patterns for ondansetron, Indion 234, 
resinate, and physical mixture of resin and drug were 
obtained on Phillips analytical X-ray BV (PW1710) (Almelo, 
the Netherlands) using Cu anode, 40 kV and current of 
30 mA.
Table 1: Ion exchange resin used
Resin Functionality Matrix Form Ion exchange capacity Particle size
Indion 204 Carboxylic acid Cross-linked polyacrylic H+ 10 meq/dry g min +100 BSS: 1% max
+200:45% max
Indion 234 Carboxylic acid Cross-linked polyacrylic K+ 5.25 meq/dry g min +100BSS: 1% max
+200:30% max
Indion 264 Carboxylic acid Cross-linked polyacrylic H+ 10 meq/dry g min +100 BSS: 1% max
+200:30% max
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IR diffraction
The Infrared spectra of ondansetron, Indion 234 and 
resinate were obtained using Fourier transform infrared 
(FTIR) spectroscopy (Jasco 460 plus, Tokyo, Japan) and 
spectra were observed over wave number 3600– 1000 cm–1.
Differential scanning calorimetry study
Universal V4.1d TA differential scanning calorimeter 
(TA Instruments, USA) was used to analyze the thermal 
behavior of ondansetron, Indion 234, and ondansetron–
Indion 234 complexes (resinate 234). Indium standard was 
used to calibrate the DSC temperature. The samples were 
heated at 10°C per minute.
In vitro release of ondansetron
Weighed quantity of resinate equivalent to normal dose 
was subjected to dissolution studies using USP type II 
dissolution apparatus at 100 rpm with temperature of 37 
± 0.5°C and 900 mL 0.1 N HCl used as the dissolution 
medium. An aliquot equal to 5 mL was withdrawn at 
specific time interval, and it was filtered through Whatman 
filter paper no. 41. Absorption of the filtered solution was 
checked by UV spectroscopy at 272.6 nm and quantity of 
drug released was determined periodically (n = 5).
RESULTS AND DISCUSSION
For the preparation of resinate, batch method was used 
because of its convenience. Table 3 shows that maximum 
amount of ondansetron binds to Indion 234 (drug content 
46.30%) while Indion 204 and Indion 264 reported 
36.96% and 42.88% drug content, respectively. This can 
be attributed to the difference of cross-linking, exchange 
capacity, and form of resin. The loading capacity of 
Indion 234 is a function of exchange of K+ ions in the 
resin with ions in solution.[15] Further attempt was made to 
optimize the drug-loading process by carrying out loading 
at different drug:resin concentration which showed 1:1 as 
the best ratio [Table 4]. An increase in amount of resin 
does not give correspondingly high increment in % drug 
content. It was seen that pH has no significant effect on 
drug loading [Table 5]. This can be explained as pKa of 
the drug is 7.4 which means the drug is ionized over entire 
pH range over which drug-binding studies are done while 
resin which has weak acid functionality (–COOH) will 
show better ionization at lower pH. Hence, pH of loading 
solution (3.5) was used for drug loading. Thus, resinate 
prepared by batch method using Indion 234 in drug:resin 
ratio of 1:1 at pH 3.5 gives optimum loading. The % drug 
content of optimized resinate was 44.75%. The drug 
content of resinate by dissolution was found to be 44.79%; 
the release of drug in deionized water was negligible (0.4%) 
which shows stability of complex in aqueous environment. 
Evaluation of taste was done using procedure described 
in WHO guidelines for determination bitterness value of 
bitter medicinal plant extracts and method described in 
the literature which is a fast and semiquantitative method 
and overcomes subjectiveness of time intensity method 
described in earlier literature.[16] Most volunteers reported 
the threshold bitterness at 20 µg/mL. The time for this 
threshold bitterness concentration to be achieved in buffer 
of salivary pH showed that the drug is not released in 
saliva to attain threshold bitterness concentrations thereby 
masking the bitter taste satisfactorily [Tables 6 and 7].
The complexation was confirmed by carrying out X-ray 
powder diffraction study on Indion 234, drug, and 
resinate. Ondansetron is crystalline whereas Indion 234 
is amorphous resin. The molecular state of the drug in 
resinate shows hallow-diffused pattern and the absence 
Table 2: Ondansetron profile
Molecular weight 293.8
Bioavailability Approximately 60%
pKa 7.4
Elimination t1/2 4.1–11.6 h (oral) 2.5–6 h (IV)
Excretion Renal
Solubility Water soluble (10 mg/mL), insoluble in alcohol, 
acetone, methanol
Table 3: Selection of resin (n = 3)
Resin Drug:resin ratio % Drug content of 
resinate
Indion 204 1:1 36.57 ± 0.4791
Indion 234 1:1 46.30 ± 0.3660
Indion 264 1:1 42.10 ± 0.3223
Table 4: Effect of drug:resin ratio on loading (n = 3)
Resin Drug:resin ratio % Drug content of 
resinate
Indion 234 1:0.5 58.02 ± 0.4083
1:1 46.30 ± 0.3885
1:1.5 37.75 ± 0.1836
1:2 32.20 ± 0.2405
Table 5: Effect of pH on loading (n = 3)
Resin Ratio pH % Drug content of resinate
Indion 234 1: 1 2 41.26 ± 0.2567
3 43.18 ± 0.4718
3.5 44.45 ± 0.376
5 45.43 ± 0.379
6 46.17 ± 0.3325
7 44.68 ± 0.3687
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of drug peaks.[6] This confirms that the entrapped drug 
is dispersed monomolecularly in the resin bead. The 
difference in peaks obtained at various θ values reveals 
that the samples are different from each other [Figure 1].
The IR spectra of ondansetron, Indion 234, and resinate 
are depicted in Figure 2. Drug spectrum shows a prominent 
peak at 3320.82 cm–1 corresponding to the –NH2 stretching 
in a secondary amine. Aromatic ring and carbonyl group 
also present in drug interaction. Indion 234 shows 
characteristic peaks at 1674 cm–1 corresponding to –C=O 
stretching of aryl acids and at 1602 cm–1 due to aromatic 
C=C stretching. The absence of peak (3320.82 cm–1) in 
IR spectrum of resinates confirms complexation of the 
secondary amine group in the drug with resin [Figure 3].
The thermal behavior of the pure drug shows endotherm 
at 181.16 and 244.10°C corresponding to melting and 
Table 6: Determination of threshold bitterness concentration
Volunteers 1 2 3 4 5 6 7
Threshold bitterness concentration (µg/mL) 10 10 20 20 20 20 20
Table 7: Time for attainment of threshold bitterness concentration in vitro (n = 5)
Stirring time (s) 0 5 10 30 60 120
Concentration (µg/mL) 1.25 ± 0.124 1.45 ± 0.2587 1.57 ± 0.2478 1.91 ± 0.1569 3.75 ± 0.1782 6.62 ± 0.2247
Table 8: Micromeritic properties of resin 234 and 
resinate (n = 3)
Property Drug Resinate
Carr index
Bulk density
Angle of repose
19.86%
0.3125 g/mL
27.89
21.12%
0.377 g/mL
28.24
Figure 1: X-ray powder diffraction of ondansetron, Indion 234 and 
ondansetron—Indion 234 resinate
Figure 3: Differential scanning thermograms ondansetron, Indion 234 
and ondansetron—Indion 234 resinate
Figure 2: Infrared spectra of (A) ondansetron, (B) Indion 234 and (C) 
ondansetron—Indion 234 resinate.
Figure 4: In vitro drug release from Indion 234–ondansetron resinate
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degradation. Indion 234 shows endotherm near 126° and 
298°C whereas resinate shows endotherm near 254°C thus 
indicating complexation. 
The complex was subjected to dissolution studying 0.1 N 
HCl using USP 23, paddle apparatus at 100 rpm at 37 ± 
1°C shown that drug release was more that 80% [Figure 4].
Further, the micromeritic properties were evaluated using 
properties such as bulk density, angle of repose, and 
compressibility (Carr) index are calculated in Table 8. It 
was found that all the properties of resin and resinate 
were similar and the flow and compressibility of resinates 
are satisfactory.
CONCLUSION
This incorporates the study on formulation of tasteless 
complexes of ondansetron with ion exchange resin and 
evaluation of molecular properties of drug complex. 
Drug loading was performed using various resins and 
was optimized using different drug:resin ratio and pH. 
Drug–resin complexes were characterized by infrared 
spectroscopy, thermal analysis, and X-ray powder 
diffraction (XRPD). Indion 234 gave best-loading 
efficiency, and it was also reported that pH had no effect 
on drug loading. It was revealed by XRPD studies that 
drug was in amorphous state in complex and the IR 
studies revealed complexation of secondary amine group 
of drug with carboxylic functional group of resin. Taste 
evaluation done by semiquantitative method established 
that resonates were tasteless and agreeable. The release of 
drug from resinates in simulated gastric fluid was complete 
in 30 min. Thus, it was shown that ion exchange resinates 
can be effectively used for masking bitter taste and also to 
improve drug release.
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